EU Regulators Make Finding & Using RWD Easier

Two new electronic catalogs of real-world data sources and studies offer an improved and more efficient service to help drug companies, regulators and researchers find adequate data sources to generate real-world evidence for regulatory purposes, says the European Medicines Agency.

Improving discoverability of data is one of the priorities of the EU drug regulators • Source: Shutterstock

EU regulators have launched two public electronic catalogs of real-world data (RWD) sources and studies that they believe will better help drug companies, regulators and researchers identify and use such data when investigating the use, safety and effectiveness of medicines.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Real-World Evidence

More from Clinical Trials